FMP
ADVM

Financial Management Professionals’s Adverum Biotechnologies ADVM Stock Holding History

Financial Management Professionals’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10
Closed -$1K – 302
2019
Q4 		$1K Buy
+10
New +$881 ﹤0.01% 297
2019
Q3 		– Sell
-30
Closed -$4K – 298
2019
Q2 		$4K Buy
+30
New +$2.48K ﹤0.01% 240

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Financial Management Professionals's ADVM Position: Q1 2020 in Review

Financial Management Professionals sold out of Adverum Biotechnologies (ADVM) in Q1 2020, closing a stake of 10 shares — an estimated $1K sold.

Financial Management Professionals first reported a position in ADVM in Q2 2019 and held it in 2 quarters. The position peaked at $4K in Q2 2019. 126 funds tracked by Wall St. Rank hold ADVM as of Q1 2020.

  • Financial Management Professionals reported no remaining Adverum Biotechnologies position as of Q1 2020 after selling out during the quarter.
  • Financial Management Professionals sold 10 Adverum Biotechnologies shares in Q1 2020, an estimated $1K.
  • Financial Management Professionals first reported a position in Adverum Biotechnologies in Q2 2019 and held it in 2 quarters.
  • Financial Management Professionals's Adverum Biotechnologies position peaked at $4K in Q2 2019.
  • 126 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2020.

Based on Financial Management Professionals's 13F filing for Q1 2020, filed 24 Apr 2020.